These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22067143)

  • 21. The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study.
    DiBella EV; Fluckiger JU; Chen L; Kim TH; Pack NA; Matthews B; Adluru G; Priester T; Kuppahally S; Jiji R; McGann C; Litwin SE
    Int J Cardiovasc Imaging; 2012 Aug; 28(6):1435-44. PubMed ID: 21968545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.
    Goudarzi B; Fukushima K; Bravo P; Merrill J; Bengel FM
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1908-16. PubMed ID: 21656246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regadenoson stress for myocardial perfusion imaging.
    Reyes E
    Future Cardiol; 2016 Jan; 12(1):59-67. PubMed ID: 26639775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daily Caffeine Consumption Is Associated with Decreased Incidence of Symptoms and Hemodynamic Changes During Pharmacologic Stress with Regadenoson.
    Posch MI; Kay MD; Harhash AA; Huang JJ; Krupinski EA; Abidov A; McMillan NA; Kuo PH
    J Nucl Med Technol; 2020 Mar; 48(1):73-76. PubMed ID: 31604901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging.
    Thomas DM; Minor MR; Aden JK; Lisanti CJ; Steel KE
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):96. PubMed ID: 29202847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement.
    van Nunen LX; Lenders GD; Schampaert S; van 't Veer M; Wijnbergen I; Brueren GR; Tonino PA; Pijls NH
    EuroIntervention; 2015 Dec; 11(8):905-13. PubMed ID: 25136887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson.
    Noel CV; Krishnamurthy R; Moffett B; Krishnamurthy R
    Pediatr Radiol; 2017 Mar; 47(3):280-289. PubMed ID: 28035425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson.
    Bhave NM; Freed BH; Yodwut C; Kolanczyk D; Dill K; Lang RM; Mor-Avi V; Patel AR
    J Cardiovasc Magn Reson; 2012 Dec; 14(1):89. PubMed ID: 23272658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial Stress Perfusion MRI: Experience in Pediatric and Young-Adult Patients Following Arterial Switch Operation Utilizing Regadenoson.
    Noel CV; Krishnamurthy R; Masand P; Moffett B; Schlingmann T; Cheong BY; Krishnamurthy R
    Pediatr Cardiol; 2018 Aug; 39(6):1249-1257. PubMed ID: 29748700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.
    Friedman M; Spalding J; Kothari S; Wu Y; Gatt E; Boulanger L
    J Med Econ; 2013; 16(4):449-60. PubMed ID: 23363331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.
    Hendel RC; Bateman TM; Cerqueira MD; Iskandrian AE; Leppo JA; Blackburn B; Mahmarian JJ
    J Am Coll Cardiol; 2005 Dec; 46(11):2069-75. PubMed ID: 16325044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve.
    Arumugham P; Figueredo VM; Patel PB; Morris DL
    EuroIntervention; 2013 Feb; 8(10):1166-71. PubMed ID: 23164748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, multicenter, multivendor study of myocardial perfusion imaging with regadenoson CT perfusion vs single photon emission CT.
    Cury RC; Kitt TM; Feaheny K; Blankstein R; Ghoshhajra BB; Budoff MJ; Leipsic J; Min JK; Akin J; George RT
    J Cardiovasc Comput Tomogr; 2015; 9(2):103-12.e1-2. PubMed ID: 25726411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in pharmacologic stress agents: focus on regadenoson.
    Johnson SG; Peters S
    J Nucl Med Technol; 2010 Sep; 38(3):163-71. PubMed ID: 20724531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regadenoson versus dipyridamole hyperemia for cardiac PET imaging.
    Johnson NP; Gould KL
    JACC Cardiovasc Imaging; 2015 Apr; 8(4):438-447. PubMed ID: 25797122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.
    Bravo PE; Pozios I; Pinheiro A; Merrill J; Tsui BM; Wahl RL; Bengel FM; Abraham MR; Abraham TP
    Am J Cardiol; 2012 Oct; 110(7):1033-9. PubMed ID: 22748357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls.
    Burrage MK; Shanmuganathan M; Masi A; Hann E; Zhang Q; Popescu IA; Soundarajan R; Leal Pelado J; Chow K; Neubauer S; Piechnik SK; Ferreira VM
    Int J Cardiol; 2021 Jun; 333():239-245. PubMed ID: 33705843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regadenoson-stress myocardial CT perfusion and single-photon emission CT: rationale, design, and acquisition methods of a prospective, multicenter, multivendor comparison.
    Cury RC; Kitt TM; Feaheny K; Akin J; George RT
    J Cardiovasc Comput Tomogr; 2014; 8(1):2-12. PubMed ID: 24314823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography.
    Karamitsos TD; Leccisotti L; Arnold JR; Recio-Mayoral A; Bhamra-Ariza P; Howells RK; Searle N; Robson MD; Rimoldi OE; Camici PG; Neubauer S; Selvanayagam JB
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):32-40. PubMed ID: 19920032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.